HSBC Upgrades Bayer to Buy, Boosts PT

Published on 06/11/2025 at 08:34

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Bayer AG

Orion Q2 operating profit EUR 104.6 mln	Jul. 18	RE
AlphaValue/Baader Europe Notes Continued Upside in Novartis After Q2 Results	Jul. 17	MT
Bayer CEO to Stay at Helm Until March 2029	Jul. 16	DJ
Bayer extends contract of CEO until March 2029	Jul. 16	RE
Bayer extends contract of CEO until March 2029	Jul. 16	RE
Bayer supervisory board extends contract of CEO Bill Anderson	Jul. 16	RE
Global markets live: Tesla, Gilead, Kenvue, Amazon, Bayer…	Jul. 14
Bayer Shares Buoyed by US Drug Approval Amid Weak Market	Jul. 14	DP
Bayer's Finerenone Secures New US FDA Indication for Heart Failure Type	Jul. 14	MT
Bayer: Fineronone approved for heart failure in US	Jul. 14
Bayer: new distribution agreement with M2i	Jul. 14
Bayer Expands M2i Group Distribution Deal to Asia-Pacific, Latin America, US	Jul. 14	MT
US FDA Approves Bayer's Heart Failure, Left Ventricular Ejection Fraction Treatment	Jul. 14	MT
Bayer AG announces US FDA approved Kerendia	Jul. 14	RE
Bayer says to expand partnership with M2i Group to distribute pheromone-based biological crop protection solutions globally	Jul. 14	RE
Bayer says U.S. FDA approves finerenone	Jul. 14	RE
BAYER AG : Jefferies reiterates its Neutral rating	Jul. 11	ZD
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	Jul. 11	RE
Bayer Receives U.K. Approval for Hot Flashes Treatment	Jul. 10	DJ
Bayer receives approval for Lynkuet(TM) (Elinzanetant) in UK	Jul. 10	RE
Bayer Rules Out Further Plant Closures in Germany After Frankfurt Exit	Jul. 10	RE
Reaches socially acceptable agreements for the withdrawal from Frankfurt/Main site and secures remaining company sites in Germany until 2030	Jul. 10	RE
Bayer Submits Gadoquatrane for EU Approval to Offer Lower-dose MRI Contrast Agent	Jul. 10	MT
Bayer: application for approval of its contrast agent	Jul. 10
Bayer Seeks EU Approval for Low-Dose MRI Contrast Agent Gadoquatrane	Jul. 10	MT